The Ensign Group Q3 Earnings Call Highlights

Impact · against what's priced in

ENSG is a buy on the back of a raised 2026 EPS guidance and expanding operating margins. While the entry into Florida introduces a short-term drag on performance, the company's strong liquidity and positive same-store occupancy trends support continued aggressive acquisition growth.

ENSG+0.60

No priced-in read yet

In context

The company raised its 2026 adjusted EPS guidance to $7.94-$8.02 from $7.75-$7.85, supported by a 23.8% growth in adjusted EPS and expanding margins (revenue grew 14.5% while adjusted net income grew 24.9%).

Read from the article alone

• ENSG▲54%
• earnings▲8%
• guidance▲<1%
• healthcare
• m and a
• acquisitions
• florida